Position in BYSI
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$26,250
+$1,650 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 22 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BYSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $7,258,442 across 7 Biotechnology names. BYSI ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
22,028 | $5,391,793 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
132,256 | $751,214 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
742 | $368,573 | |
| 4 | DMAC |
DiaMedica Therapeutics Inc.
|
43,600 | $306,944 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
801 | $253,188 | |
| 6 | NMRA |
Neumora Therapeutics, Inc.
|
94,400 | $160,480 | |
| 7 | BYSI |
BeyondSpring Inc.
This page
|
15,000 | $26,250 |
All Filings in BYSI
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,250 | 15,000 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $24,600 | 15,000 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||